• News
  • SAN DIEGO
  • BioTech

Ambit Biosciences' revenue down in 2Q

San Diego-based Ambit Biosciences (Nasdaq: AMBI) reported Wednesday revenues in the second quarter of 2014 were $26,000, compared to $11.5 million in the second quarter of 2013.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!